| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |